US 7459462
Fredericamycin derivatives
granted A61PA61P25/02A61P33/00
Quick answer
US patent 7459462 (Fredericamycin derivatives) held by Biofrontera Discovery GmbH expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biofrontera Discovery GmbH
- Grant date
- Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P25/02, A61P33/00, A61P35/00, A61P37/06